Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma

被引：293

作者：

Yamashita, K

Upadhyay, S

Osada, M

Hoque, MO

Xiao, Y

Mori, M

Sato, F

Meltzer, SJ

Sidransky, D

机构：

[1] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA

[2] Kyushu Univ, Inst Med, Dept Surg Oncol, Beppu, Oita 8740838, Japan

[3] Univ Maryland, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21201 USA

[4] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA

[5] Baltimore VA Hosp, Baltimore, MD 21201 USA

来源：

CANCER CELL | 2002年 / 2卷 / 06期

关键词：

D O I：

10.1016/S1535-6108(02)00215-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We performed a comprehensive survey of commonly inactivated tumor suppressor genes in esophageal squamous cell carcinoma (ESCC) based on functional reactivation of epigenetically silenced tumor suppressor genes by 5-aza-2'-deoxycytidine and trichostatin A using microarrays; containing 12599 genes. Among 58 genes identified by this approach, 44 (76%) harbored dense CpG islands in the promoter regions. Thirteen of twenty-two tested gene promoters were methylated in cell lines, and ten in primary ESCC accompanied by silencing at the mRNA level. Potent growth suppressive activity of three genes including CRIP-1, Apolipoprotein D, and Neuromedin U in ESCC cells was demonstrated by colony focus assays. Pharmacologic reversal of epigenetic silencing is a powerful approach for comprehensive identification of tumor suppressor genes in human cancers.

引用

页码：485 / 495

页数：11

共 70 条

[61] Usadel H, 2002, CANCER RES, V62, P371
[62] Colorectal cancer in mice genetically deficient in the mucin Muc2
Velcich, A
Yang, WC
Heyer, J
Fragale, A
Nicholas, C
Viani, S
Kucherlapati, R
Lipkin, M
Yang, K
Augenlicht, L
[J]. SCIENCE, 2002, 295 (5560) : 1726 - 1729
[63] The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer
Visvader, JE
Venter, D
Hahm, K
Santamaria, M
Sum, EYM
O'Reilly, L
White, D
Williams, R
Armes, J
Lindeman, GJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14452 - 14457
[64] TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C
Deng, L
Hong, M
Akkaraju, GR
Inoue, J
Chen, ZJJ
[J]. NATURE, 2001, 412 (6844) : 346 - 351
[65] WILSON VL, 1983, CANCER RES, V43, P3493
[66] WO KW, 2000, CANCER RES, V60, P3348
[67] Xu Y, 2002, CANCER RES, V62, P3493
[68] The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target
Yamada, Y
Pannell, R
Forster, A
Rabbitts, TH
[J]. ONCOGENE, 2002, 21 (09) : 1309 - 1315
[69] Trichostatin and leptomycin - Inhibition of histone deacetylation and signal-dependent nuclear export
Yoshida, M
Horinouchi, S
[J]. ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 : 23 - 36
[70] SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
Yoshikawa, H
Matsubara, K
Qian, GS
Jackson, P
Groopman, JD
Manning, JE
Harris, CC
Herman, JG
[J]. NATURE GENETICS, 2001, 28 (01) : 29 - 35

← 1 2 3 4 5 6 7 →